Real-time enrollment status for this high grade glioma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:29 AM UTC
| NCT Number | NCT05632562 |
| Recruiting Status | Recruiting |
| Condition | High Grade Glioma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 2 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 18, 2026: Clinical trial NCT05632562 is currently recruiting participants. This early_phase1 study for high grade glioma is actively seeking new participants at 2 locations across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05632562 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05632562 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.